We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
-12.36%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.07B
AUM Growth
-$441M
Cap. Flow
-$81M
Cap. Flow %
-3.92%
Top 10 Hldgs %
24.52%
Holding
315
New
9
Increased
84
Reduced
155
Closed
50

Top Buys

Rank Stock Value
1
APPS icon
Digital Turbine
APPS
+$30.2M
2
ARLO icon
Arlo Technologies
ARLO
+$9.27M
3
IOVA icon
Iovance Biotherapeutics
IOVA
+$8.07M
4
CMBM
Cambium Networks
CMBM
+$5.41M
5
AIN icon
Albany International
AIN
+$5.16M

Top Sells

Rank Stock Value
1
SIMO icon
Silicon Motion
SIMO
+$26.3M
2
MIME
Mimecast Limited
MIME
+$19.2M
3
PCOM
Points.com Inc. Common Shares
PCOM
+$13.1M
4
STRA icon
Strategic Education
STRA
+$6.13M
5
APEI icon
American Public Education
APEI
+$6.11M

Sector Composition

Rank Sector Weight
1 Technology 27.57%
2 Healthcare 25.36%
3 Industrials 14.78%
4 Consumer Discretionary 12.93%
5 Communication Services 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GBCI icon
226
Glacier Bancorp
GBCI
$6.35B
$1.31M 0.06%
27,723
+838
+3% +$39.5K
BRK.B icon
227
Berkshire Hathaway Class B
BRK.B
$1.13T
$1.21M 0.06%
4,434
– –
CODA icon
228
Coda Octopus Group
CODA
$120M
$1.21M 0.06%
241,168
+6,653
+3% +$36.3K
ABBV icon
229
AbbVie
ABBV
$435B
$1.02M 0.05%
6,631
-46
-0.7% -$7.03K
TDY icon
230
Teledyne Technologies
TDY
$32B
$939K 0.05%
2,504
-52
-2% -$21.7K
URGN icon
231
UroGen Pharma
URGN
$2.29B
$905K 0.04%
110,457
+2,467
+2% +$16.9K
PRVB
232
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$903K 0.04%
225,785
+5,720
+3% +$27.1K
COLM icon
233
Columbia Sportswear
COLM
$2.94B
$891K 0.04%
12,450
-358
-3% -$28.6K
AAPL icon
234
Apple
AAPL
$4.57T
$834K 0.04%
6,100
– –
ABT icon
235
Abbott
ABT
$187B
$754K 0.04%
6,936
– –
LLY icon
236
Eli Lilly
LLY
$1.06T
$694K 0.03%
2,140
-150
-7% -$45K
DENN
237
DELISTED
Denny's
DENN
$684K 0.03%
78,846
+1,934
+3% +$21.3K
RYTM icon
238
Rhythm Pharmaceuticals
RYTM
$7.96B
$660K 0.03%
159,000
+22,479
+16% +$123K
HAS icon
239
Hasbro
HAS
$13.2B
$644K 0.03%
7,861
-385
-5% -$33.4K
IRD
240
Opus Genetics
IRD
$302M
$629K 0.03%
327,494
+182,468
+126% +$415K
CVX icon
241
Chevron
CVX
$366B
$615K 0.03%
4,251
– –
CSTL icon
242
Castle Biosciences
CSTL
$979M
$587K 0.03%
26,750
+599
+2% +$13.9K
SMID icon
243
Smith-Midland
SMID
$152M
$581K 0.03%
41,523
+1,259
+3% +$20.2K
ZYXI
244
DELISTED
Zynex
ZYXI
$531K 0.03%
66,568
+1,698
+3% +$12K
MCO icon
245
Moody's
MCO
$82.7B
$514K 0.02%
1,890
-20
-1% -$5.98K
MRK icon
246
Merck
MRK
$318B
$504K 0.02%
5,526
-75
-1% -$6.65K
PEP icon
247
PepsiCo
PEP
$190B
$496K 0.02%
2,978
– –
UPLD icon
248
Upland Software
UPLD
$15.4M
$486K 0.02%
3,347
+104
+3% +$15.2K
SYY icon
249
Sysco
SYY
$40.3B
$485K 0.02%
5,727
– –
J icon
250
Jacobs Solutions
J
$17B
$451K 0.02%
4,286
– –
8 9
10
11 12

Similar funds

WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Rice Hall James & Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Rice Hall James & Associates held 315 positions worth $2.07B, down 18% from $2.51B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates withdrew a net $81M in Q2 2022, closing 50 positions and reducing 155 holdings. Its most notable exit was Mimecast Limited, an estimated $19.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in Albany International worth $4.99M.

  • Rice Hall James & Associates's largest Q2 2022 buy was Albany International: 63,306 shares worth $4.99M.
  • Rice Hall James & Associates added most to Digital Turbine in Q2 2022, an estimated $30.2M increase.
  • Rice Hall James & Associates's biggest Q2 2022 reduction was Silicon Motion, cutting an estimated $26.3M.
  • Rice Hall James & Associates fully exited Mimecast Limited in Q2 2022, selling an estimated $19.2M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $2.07B portfolio in Q2 2022.
  • Rice Hall James & Associates opened 9 new positions and closed 50 in Q2 2022.
  • Rice Hall James & Associates's portfolio value fell 18% quarter-over-quarter to $2.07B.

Based on Rice Hall James & Associates's 13F filing for Q2 2022, filed 8 Aug 2022.